Deferasirox (ICL670)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Deferasirox (ICL670), covering 2011-05-18 to 2011-05-18. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis [Phase 1, Phase 2]